Fimasartan for Improvement of Diastolic Dysfunction in Hypertensive Patients
Phase of Trial: Phase IV
Latest Information Update: 28 Jan 2016
At a glance
- Drugs Fimasartan (Primary)
- Indications Diastolic heart failure
- Focus Therapeutic Use
- Acronyms FINE
- 31 Aug 2018 Biomarkers information updated
- 29 Dec 2015 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 22 Jun 2015 Planned End Date changed from 1 Apr 2015 to 1 Aug 2015 as per ClinicalTrials.gov record.